Why the study?
Does RGS14 attenuate pathological cardiac remodeling in response to pressure overload?
Population
Human failing hearts, murine hypertrophic hearts, isolated hypertrophic cardiomyocytes, RGS14 knockout mice…
Comparison
Genetic manipulation of RGS14, constitutive… vs Wild-type mice or control conditions
Design
Preclinical
Authors
Loading...
May protect against pressure-overload remodeling in mice; leaves open whether RGS14 targeting benefits human HF.
Does RGS14 attenuate pathological cardiac remodeling in response to pressure overload?
RGS14 attenuates pathological cardiac remodeling through the MEK-ERK1/2 signaling pathway, highlighting its potential as a therapeutic target for heart failure.
Li et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: